 |
|
|
|
Detailed Eptifibatide Description
Eptifibatide is an intravenous cyclical heptapeptide that selectively blocks the
platelet glycoprotein IIb / IIIa receptor. It has demonstrated efficacy in the treatment of patients
during coronary angioplasty, myocardial infarction and angina. It reversibly binds to platelets and
has a short half - life.
We have been a leading manufacturer and exporter of Eptifibatide
|
|
Contact information:
Inquire
| Address: |
3 / F, 201 Minii Road, Building 11, Songjiang District, Shanghai City. China |
| Company Name: |
Auspure Biotechnology Co., Ltd. |
| Contact Person: |
Mr. James Hu |
| Fax: |
86-21-57687512, 57687532 |
| Telephone: |
86-21-57687528 |
| Website: |
http://www.auspure.com |
| Zip: |
201612 |
|
|
|
|
